Study <activesubstancename> details remains in case after changing the study (Doc ID 2279877.1)

Last updated on JUNE 29, 2017

Applies to:

Oracle Argus Safety - Version 7.0.5 and later
Information in this document applies to any platform.

Symptoms


Study <activesubstancename> details remains in case .XML file information after changing the study from an unblinded study to a blinded study.
The E2B file contains the active substance details from the previously selected unblinded study in addition to the current blinded study active substance details.

Cause

Sign In with your My Oracle Support account

Don't have a My Oracle Support account? Click to get started

My Oracle Support provides customers with access to over a
Million Knowledge Articles and hundreds of Community platforms